raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:102379

Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent

Synonyms: AML and myelodysplastic syndromes related to alkylating agent

Type
Disease
Group
Disorder
Status
active

A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbor unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAcute myeloid leukemia and myelodysplastic syndromes related to alkylating agentAML and myelodysplastic syndromes related to alkylating agent
frLeucémie aiguë myéloïde et syndromes myélodysplasiques liés aux agents alkylants
deAkute myeloische Leukämie und myelodysplastische Syndrome durch alkylierende AgenzienAML und MDS durch alkylierende Agenzien
esLeucemia mieloide aguda y síndromes mielodisplásicos relacionados con agentes alquilantesLMA y síndromes mielodisplásicos asociados a agentes alquilantes
itLeucemia mieloide acuta e sindromi mielodisplastiche correlate ad un agente alchilanteAML e sindromi mielodisplastiche associate ad un agente alchilante
nlAcute myeloïde leukemie en myelodysplastische syndromen gerelateerd aan alkylerend middelAML en myelodysplastische syndromen gerelateerd aan alkylerend middel
ptLeucemia mielóide aguda e síndromes mielodisplásticos relacionados com agentes alquilantes
plOstra białaczka szpikowa i zespoły mielodysplastyczne związane z czynnikiem alkilującymAML i zespoły mielodysplastyczne związane z czynnikiem alkilującym
csAkutní myeloidní leukémie a myelodysplastický syndrom související s alkylačním činidlemAML a myelodysplastický syndrom související s alkylačním činidlem
ukГострий мієлоїдний лейкоз та мієлодиспластичні синдроми, повязані з алкілуючим агентомГМЛ та мієлодиспластичні синдроми, повязані з алкілуючим агентом
zh烷化剂相关急性髓系白血病及骨髓增生异常综合征与烷化剂相关的急性髓系白血病和骨髓增生异常综合征
trAkut miyeloid lösemi ve alkilleyici ajanla -ilişkili miyelodisplastik sendromlarAlkilleyici ajanla ilişkili AML ve miyelodisplastik sendromlar

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C92.8NTBTattributedvalidated
ICD-112A60.20NTBTindexvalidated
MONDO0015164Evalidated
UMLSC1332234Evalidated
GARD19835Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

0 records

No prevalence record in this release.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card